Press Release

Immunodiagnostics Market Size 2019 Global Industry Analysis, challenges, Top anufacturers, Share, Growth, Opportunities, issues and companies involved and Forecast to 2025

Immunodiagnostics Market Is Expected to Grasp US$ 22,732.7 Mn by 2025, at a CAGR Of 4.7% Says Fortune Business Insights

The increasing number of geriatric population, and occurrences of infectious diseases like cancer, and hepatitis is expected to boost the global immunodiagnostics market. According to a report published by Fortune Business Insights, titled “Immunodiagnostics: Global Market Analysis, Insights, and Forecast, 2018-2025,” the market was valued at US$ 15,777.5 Mn in 2017. Fortune Business Insights predicts that the market will rise at a CAGR of 4.7%, and reach US$ 22,732.7 Mn by the end of 2025.

Oncology and Endocrinology Segment Will Witness Increasing Demand

The immunodiagnostic market is categorized into oncology and endocrinology, infectious disease testing, hepatitis and retrovirus testing, and GI stool testing in terms of application. In 2017, oncology, and endocrinology segment had generated a market share of 25.6%. The segment’s highest share is accredited to the embracing of immunodiagnostics in various applications, namely endocrine diseases and cancer. There has been an increase in the number of reimbursement of products as well as new product approvals. Also, several tests are predicted to propel the global immunodiagnostics market by the end of 2025.

Request Sample [email protected] https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/immunodiagnostics-market-100444

TABLE OF CONTENT:

  1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

  1. Executive Summary
  2. Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

  1. Key Insights

4.1 Technological Advancements

4.2 Key Industry Developments -Mergers, Acquisitions and Partnerships

4.3 Reimbursement Scenario

4.4 Key Performance Indicators for Global Immunodiagnostics Market

  1. Global Immunodiagnostics Market Analysis, Insights and Forecast, 2014-2025

5.1. Key Findings / Summary

5.2. Market Analysis, Insights and Forecast – By Product

5.2.1 Instruments

5.2.2 Reagents & Consumables

5.3. Market Analysis, Insights and Forecast – By Application

5.3.1 Oncology& Endocrinology

5.3.2 Hepatitis & Retrovirus

5.3.3 Cardiac Markers

5.3.4 Infectious Diseases

5.3.5 Others

5.4. Market Analysis, Insights and Forecast – By End User

5.4.1 Clinical Laboratories

5.4.2 Hospitals

5.4.3 Physician’s Offices

5.4.4 Others

5.5. Market Analysis, Insights and Forecast – By Region

5.5.1 North America

5.5.2 Europe

5.5.3 Asia Pacific

5.5.4 Latin America

5.5.5 Middle East & Africa

Asia Pacific to Remain Dominant in the Market

The global immunodiagnostics market can be geographically segmented into Latin America, North America, Asia Pacific, Middle East, Europe and Africa. Amongst these regions, the Asia Pacific market was worth US$ 3,949.1 Mn in 2017, and it is still likely to generate a comparatively high CAGR during the forecast period. As there is an increasing awareness among the masses regarding disease management, it encourages them to go for regular health check-ups and tests. This has also enhanced the global immunodiagnostics market.

 

 

Tags

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close